Matt Maley shares his stock picks for a volatile market. He likes Meta Platforms (META), which he believes is undervalued and has a strong fundamental backdrop, trading at 23 times earnings and having generated over $50 billion in free cash flow last year. Maley also likes JPMorgan Chase (JPM), which he thinks could benefit from a potential M&A and IPO pickup, and Pfizer (PFE), which he sees as a defensive play with a 6.5% dividend yield and a reasonable valuation at 11 times earnings.